CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.
Hirsutism - Management
What treatments may be used in secondary care?
- Systemic treatments that may be used in secondary care include:
- Anti-androgens (such as high-dose cyproterone acetate, spironolactone, and flutamide).
- 5-alpha-reductase inhibitors (such as finasteride).
- Insulin-sensitizing drugs (such as metformin and the glitazones [pioglitazone and rosiglitazone]).
- Gonadotrophin-releasing hormone analogues (such as goserelin and leuprorelin).
© NHS Institute for Innovation and Improvement